WORLD AstraZeneca files bid for vaccine authorisation: EU medicines agency

WORLD

AstraZeneca files bid for vaccine authorisation: EU medicines agency

AFP

16:13, January 12, 2021

Patients receive an injection of the Oxford/AstraZeneca Covid-19 vaccine at a mass vaccination centre at Epsom Downs Racecourse in Epsom, southern England on January 11, 2021. (Photo: AFP)

AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the European Union with a decision possible by January 29, The European Medicines Agency said on Tuesday.

The jab would be the third available for the 27-nation EU after the Pfizer-BioNTech and Moderna drugs, as the bloc struggles to speed up the rollout.

"EMA has received an application for conditional marketing authorisation for a COVID-19 vaccine developed by AstraZeneca and Oxford University," the Amsterdam-based regulator said in a statement.

The EMA said its assessment would "proceed under an accelerated timeline".

"An opinion on the marketing authorisation could be issued by 29 January... provided that the data submitted on the quality, safety and efficacy of the vaccine are sufficiently robust and complete," it said.

The EU and the EMA have been under pressure to speed up the approval of new vaccines against the virus, which has claimed the lives of more than 620,000 people across the continent.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue